Rss Feed
Hurricane Sandy survivors face elevated heart risks long after the storm
Researchers studying Medicare beneficiaries found that Hurricane Sandy–related flooding modestly increased cardiovascular disease risk for up to five years. Heart failure drove much of the rise, particularly in New Jersey, with short-term and delayed spikes observed.
Why universal COVID-19 vaccine guidance offers stronger protection than high-risk-only policies
The US Scenario Modeling Hub’s nine-team ensemble projected COVID-19 hospitalizations and deaths for April 2024 to April 2025 under six policy and immune-escape scenarios. Burden was similar to the prior year, with universal vaccination recommendations averting more outcomes than high-risk-only guidance, especially for adults aged 65 years and older.
Rising ozone from wildfire smoke poses growing health risks for Western communities
As wildfires grow larger and more frequent across the West, researchers from Colorado, Utah, and California are digging into how smoke affects the air-and our health.
UC Davis wins NSF grants to advance AI-driven protein engineering
Two projects at the University of California, Davis, that use artificial intelligence to design and engineer proteins for industrial and health applications have been funded by the U.S. National Science Foundation (NSF).
Inhaling marijuana associated with increased odds of developing asthma
If you're looking to reduce your chances of developing lung disease, say experts at UC San Francisco, then it may be smart to avoid inhaling cannabis.
Study in Florida finds racial disparities in heart attack treatment
While acute myocardial infarction - commonly referred to as a heart attack - remains a leading cause of death in the United States, deaths have decreased significantly over the past two decades in part due to improved treatment methods, according to Charleen Hsuan, associate professor of health policy and administration at Penn State.
Glucose-fructose mix found in sugary drinks fuels colorectal cancer metastasis
A new study from researchers at The University of Texas MD Anderson Cancer Center shows that the glucose-fructose mix found in sugary drinks directly fuels metastasis in preclinical models of advanced colorectal cancer.
Study points to a surprising new ally in the fight against type 2 diabetes
A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation - and pointing to a surprising new ally in the fight against type 2 diabetes.
Metabolic activity found to control the tempo of embryo segmentation clock
Pregnant women rely on a balanced diet and supplements to deliver proper nutrients to their babies, to ensure they grow healthfully.
UNM researcher develops new model for characterizing different forms of vascular dementia
Vascular dementia - cognitive impairment caused by disease in the brain's small blood vessels - is a widespread problem, but it has not been as thoroughly studied as Alzheimer's disease, in which abnormal plaques and protein tangles are deposited in neural tissue.
Adults with both Down Syndrome and congenital heart defects show remarkable resilience
Adults with both Down Syndrome and congenital heart defects, also known as congenital heart disease (CHD), are showing remarkable resilience despite facing significant medical challenges, according to a new MUSC study in Pediatric Cardiology.
National Institute of Mental Health awards $3.6M grant to advance ADHD medication response research
Approximately 7 million children in the United States between the ages of three and 17 have been diagnosed with attention deficit hyperactivity disorder (ADHD), according to the Centers For Disease Control and Prevention.
Survey reveals why some people turn to unregulated cannabis to treat medical conditions
Use of medical cannabis has been on the rise since it first became available to Utah patients in 2020. A medical cannabis card, which can be prescribed for difficult-to-treat conditions including PTSD and chronic pain, allows a patient to access licensed cannabis products in designated pharmacies.
Closed Loop Medicine launches first personalized GLP-1 dosing platform In U.S.
Closed Loop Medicine Ltd (CLM), a leader in personalized pharmaceutical dosing, today announced the U.S. launch of WeDosify, which enables clinicians to personalize GLP-1 titration at scale.
AI tool analyzes brain activity to support and prioritize autism assessments
Scientists have developed and tested a deep-learning model that could support clinicians by providing accurate results and clear, explainable insights – including a model-estimated probability score for autism.
New findings support low-dose ATG to delay progression of type 1 diabetes
New research presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published simultaneously in The Lancet shows that a much lower dose than previously thought of the old immunomodulatory drug anti-thymocyte globulin (ATG) is safe and effective in preventing progression of type 1 diabetes (T1D) in young people.
Study uncovers new strategy to boost life-saving cervical cancer screenings
Cervical cancer is the fourth most common cancer among women globally, according to the World Health Organization. It accounted for 660,000 new cases and 350,000 deaths in 2022.
Genomic testing speeds patient accrual in high-risk prostate cancer trial
The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed accrual and met its accrual milestone of 2,478 patients approximately two years earlier than the trial's anticipated accrual completion date.
Hyperemesis gravidarum associated with increased neuropsychiatric disorders in pregnancy
The largest study on pregnant women with excessive nausea and vomiting (hyperemesis gravidarum) has identified increased risks of numerous neuropsychiatric and mental health outcomes.
Study identifies immune biomarkers for personalized therapies in pediatric germ cell tumors
A study conducted by the Molecular Oncology Research Center (CPOM) at Hospital de Amor in Barretos (formerly Barretos Cancer Hospital) in the state of São Paulo, Brazil, has identified possible biomarkers that could guide the development of more personalized therapies for pediatric germ cell tumors (GCTs).